News
Hosted on MSN2mon
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III StudyLLY’s orforglipron is an investigational, once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake.
Stocks of LLY, VKTX and GPCR, which make oral pills for obesity, ... Notably, amylin originates in the pancreas and is responsible for reducing food intake by delaying stomach emptying, ...
LLY’s orforglipron is an investigational, once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake.
LLY’s orforglipron is an investigational, once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback